Management of homozygous familial hypercholesterolaemia--unmet needs, updated recommendations, and clinical experience with the MTP inhibitor, lomitapide. Concluding comments

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)52
Number of pages1
JournalAtherosclerosis Supplements
Volume15
Issue number2
DOIs
Publication statusPublished - Sep 1 2014

Keywords

  • Apheresis
  • Drug–drug interactions
  • Homozygous familial hypercholesterolaemia
  • Lomitapide
  • Transaminase elevations

ASJC Scopus subject areas

  • Medicine(all)

Cite this